AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
Spirovant has announced the commencement of its Phase I/II study with the first patient receiving a dose of SP-101 to treat ...
GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...
The two-day Oncology event will see industry experts from across the clinical trial space holding talks on subjects from AI ...
This research will inform the final design of the Exact Sciences Cancerguard test. Credit: Studio Romantic via Shutterstock. Exact Sciences has unveiled new findings from a case-control study ...